Lyell Immunopharma, Inc. (LYEL) ROA
- 2026-06-30: ROA -79.86%.
- 2026-03-31: ROA -70.28%.
- 2025-12-31: ROA -80.71%.
- 2025-09-30: ROA -79.83%.
Complete source-backed roa history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -79.86% |
|---|
| 2026-03-31 | -70.28% |
|---|
| 2025-12-31 | -80.71% |
|---|
| 2025-09-30 | -79.83% |
|---|
| 2025-06-30 | -85.98% |
|---|
| 2025-03-31 | -77.83% |
|---|
| 2024-12-31 | -69.88% |
|---|
| 2024-09-30 | -32.94% |
|---|
| 2024-06-30 | -32.14% |
|---|
| 2024-03-31 | -32.89% |
|---|
| 2023-12-31 | -31.28% |
|---|
| 2023-09-30 | -23.91% |
|---|
| 2023-06-30 | -25.08% |
|---|
| 2023-03-31 | -20.66% |
|---|
| 2022-12-31 | -19.53% |
|---|
| 2022-09-30 | -26.44% |
|---|
| 2022-06-30 | -23.20% |
|---|
| 2022-03-31 | -24.56% |
|---|
| 2021-12-31 | -22.19% |
|---|
| 2021-09-30 | -17.14% |
|---|
| 2021-06-30 | -15.63% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -80.71% |
|---|
| 2024-12-31 | -69.88% |
|---|
| 2023-12-31 | -31.28% |
|---|
| 2022-12-31 | -19.53% |
|---|
| 2021-12-31 | -22.19% |
|---|
| 2020-12-31 | -22.51% |
|---|